Acupressure and fatigue in patients with end-stage renal disease - a randomized controlled trial

被引:75
|
作者
Tsay, SL [1 ]
机构
[1] Natl Taipei Coll Nursing, Grad Inst Nursing, Taipei, Taiwan
关键词
acupressure; fatigue; ESRD;
D O I
10.1016/S0020-7489(03)00079-8
中图分类号
R47 [护理学];
学科分类号
1011 ;
摘要
The purpose of the study is to investigate the effectiveness of acupressure on fatigue in patients with end-stage renal-disease (ESRD). The study was a randomized control trial; qualified patients were randomly assigned into acupressure group, sham group or control group. A total of 106 participants were included in the study. The measures included the revised Piper Fatigue Scale (PFS), VAS of Fatigue, the Pittsburgh Sleep Quality Index and the Beck Depression Inventory. Data of fatigue measures were collected at pretreatment and a week following treatment. Sleep quality and depression were collected during post-test only. The statistical methods included the descriptive statistics, one-way ANOVA, ANCOVA, and repeated-measures ANOVA. ANCOVA that adjusted for differences in baseline fatigue scores (PFS), post-test of depression and sleep quality, result was significant, F(2, 100) = 3.99, p = 0.02. Post-hoc tests revealed that patients in the acupressure group were significantly having lower scores of fatigue than patients in the control group. ANCOVA results also significant for VAS of Fatigue among groups, F(2, 100) = 5.63, p = 0.003. Comparisons indicated that there were significant differences between the acupressure group and the control group (p = 0.01) and between the sham group and control group (p = 0.003). Predialysis fatigue was assessed routinely by using a rating of 0-10. Repeated-measures ANOVA results demonstrate the group main effect was significant in the perceived fatigue (F(2, 88) = 19.46, p < 0.00 1). Followup tests indicated there were significant differences between the acupressure group and the control group (p < 0.00 1) and between the sham group and control group (p < 0.001). The study provided an alternative method for health care providers to managing ESRD patients with fatigue. (C) 2003 Elsevier Ltd. All rights reserved.
引用
收藏
页码:99 / 106
页数:8
相关论文
共 50 条
  • [31] Protocol of a mixed method, randomized controlled study to assess the efficacy of a psychosocial intervention to reduce fatigue in patients with End-Stage Renal Disease (ESRD)
    van der Borg, Wieke E.
    Schipper, Karen
    Abma, Tineke A.
    BMC NEPHROLOGY, 2016, 17
  • [32] Protocol of a mixed method, randomized controlled study to assess the efficacy of a psychosocial intervention to reduce fatigue in patients with End-Stage Renal Disease (ESRD)
    Wieke E. van der Borg
    Karen Schipper
    Tineke A. Abma
    BMC Nephrology, 17
  • [33] LACK OF DISEASE MODIFYING ACTIVITY OF CELECOXIB IN END-STAGE OSTEOARTHRITIS: A RANDOMIZED CONTROLLED TRIAL
    de Boer, T. N.
    Mastbergen, S.
    Huisman, A. M.
    Polak, A. A.
    Buijlsma, J. W.
    Lafeber, F. P.
    OSTEOARTHRITIS AND CARTILAGE, 2010, 18 : S145 - S145
  • [34] Effect of homocysteine lowering on mortality and vascular disease in advanced chronic kidney disease and end-stage renal disease - A randomized controlled trial
    Jamison, Rex L.
    Hartigan, Pamela
    Kaufman, James S.
    Goldfarb, David S.
    Warren, Stuart R.
    Guarino, Peter D.
    Gaziano, J. Michael
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2007, 298 (10): : 1163 - 1170
  • [35] A Pilot Randomized Trial of Intradialysis Yoga for Patients With End-Stage Kidney Disease
    Herron, Ann
    Cavanaugh, Kerri L.
    Umeukeje, Ebele M.
    Ikizler, T. Alp
    Birdee, Gurjeet
    KIDNEY INTERNATIONAL REPORTS, 2023, 8 (02): : 357 - 359
  • [36] The impact of mindfulness meditation on pro-inflammatory biomarkers in patients with end-stage renal disease: A randomized trial
    Alhawatmeh, Hossam
    Najadat, Ishraq
    Hweidi, Issa
    Abuhammad, Sawsan
    SAGE OPEN MEDICINE, 2024, 12
  • [37] EFFICACY AND SAFETY OF ELOBIXIBAT ON CONSTIPATION IN END-STAGE KIDNEY DISEASE PATIENTS UNDERGOING HEMODIALYSIS: A RANDOMIZED CONTROLLED TRIAL
    Jenaksornkul, Krisanapol
    Siriwattanasit, Narongrit
    Inkong, Pitchamon
    Tasanavipas, Pamila
    Varothai, Narittaya
    Tangwonglert, Theerasak
    Nata, Naowanit
    Chaiprasert, Amnart
    Supasyndh, Ouppatham
    Satirapoj, Bancha
    NEPHROLOGY, 2023, 28 : 65 - 65
  • [38] End-stage Renal Disease
    Abbasi, Maaz
    Chertow, Glenn
    Hall, Yoshio
    AMERICAN FAMILY PHYSICIAN, 2010, 82 (12) : 1512 - 1514
  • [39] Home-Based Group Education On Renal Replacement Therapy For Patients With End-Stage Renal Disease: A Multi-Center Randomized Controlled Trial.
    Massey, E.
    Gregoor, P. Smak
    Nette, R.
    van den Dorpel, M.
    van Kooij, A.
    Betjes, M.
    Zietse, R.
    Zuidema, W.
    Timman, R.
    Busschbach, J.
    Weimar, W.
    TRANSPLANTATION, 2014, 98 : 488 - 488
  • [40] B-VITAMINS AND TOTAL MORTALITY AND CARDIOVASCULAR DISEASE IN PATIENTS WITH END-STAGE RENAL DISEASE. A RANDOMIZED CLINICAL TRIAL
    Dierkes, Jutta
    Heinz, Judith
    Domroese, Ute
    Westphal, Sabine
    Kropf, Siegfried
    Neumann, Klaus Hinrich
    Luley, Claus
    ANNALS OF NUTRITION AND METABOLISM, 2009, 55 : 83 - 83